Global Urology Devices Market Forecast To 2026

LONDON, December 7, 2016 /PRNewswire/ --

Urinary Incontinence, Benign Prostatic Hyperplasia (BPH), Kidney Stone, Prostate Cancer

The global urology devices market is expected to grow at a CAGR of 5.8% from 2020-2026 and CAGR of 6.2% from 2016-2020. The market is expected to grow at a CAGR of 6.0% from 2016 to 2026. The market is estimated at $6,126.4 million in 2016, $7,793.0 million in 2020, and $10,971.3 million in 2026.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 200-page report you will receive 91 tables and 80 charts- all unavailable elsewhere.

The 200 page report provides clear detailed insight into the global urology devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope 

• Global Urology Devices Market forecasts from 2016-2026

• Urology Devices National Market forecasts from 2016-2026, covering:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
- China
- India
- Rest of the World

• Urology Devices submarket forecasts from 2016-2026 covering:
- Urinary Incontinence Devices
- Benign Prostatic Hyperplasia (BPH) Devices
- Prostate Cancer Devices
- Kidney Stone Devices

To see a report overview please email Sara Peerun on [email protected]

• Analysis of the key factors driving and restraining the growth of the urology devices market from 2016-2026

• Assessment of selected leading companies, examining recent performance and outlooks:
- C.R. Bard
- Coloplast
- Endo Pharmaceuticals
- Olympus Corporation
- Teleflex
- Braun
- Boston Scientific Corporation
- Cook Group
- Healthtronics
- Intuitive Surgical Inc
- Lumenis
- Medtronic
- Siemens Healthcare
- Urologix
- Urotech

Visiongain's study is intended for anyone requiring commercial analyses for the Urology Devices Market and leading companies. You find data, trends and predictions.

Buy our report today Global Urology Devices Market Forecast to 2026: Urinary Incontinence, Benign Prostatic Hyperplasia (BPH), Kidney Stone, Prostate Cancer.

To request a report overview of this report please emails Sara Peerun at [email protected] or call Tel: +44 (0) 20 7336 6100

Or click on https://www.visiongain.com/Report/1757/Global-Urology-Devices-Market-Forecast-to-2026

Companies and Organisations Mentioned in This Report              

Advanced Urotech

American Medical System (AMS)

Aspen Holdings

B. Braun

Boston Scientific

Business Development Bank of Canada

C.R. Bard

Carolina Lithotripsy

Center for Biologics Evaluation and Research (CBER)

Central Drug Standards Control Organization (CDSCO)

China Food and Drug Administration (CFDA)

Coloplast

Cook Group

Department of Health and Human Services

Distal Access, LLC

EastMed Inc.

Endo Pharmaceuticals Holding, Inc.

European Union (EU)

Food and Drug Administration (FDA)

Gran Plasa

Healthronics

Hill-Rom Holdings, Inc.

Intuitive Surgical

Intuitive Surgical, Inc.

Karl Storz

Kobayashi Pharmaceutical Co., Ltd.

Liberator Medical Holdings, Inc.

Lumenis

Mauna Kea Technologies

Medafor, Inc.

Medical Device Regulatory Authority of India (MDRA)

Medicon, Inc,

Medtronic

Mobile Medical Marketing, LLC

MyoPowers

Nostix, LLC

Novartis

Novation

Olympus Corporation

Par Pharmaceutical Holdings, Inc.

Pharmaceuticals Medical Devices Agency (PMDA)

Rochester Medical, Inc.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Siemens

SonoMotion

Spirus Medical, Inc.

Teleflex Inc.

Terumo Corporation

Therapeutic Goods Administration (TGA)

TransEnterix

Truffle Capital

United Therapies, LLC

Urologix

Urotech

World Bank

World Health Organization

To see a report overview please email Sara Peerun on [email protected]

SOURCE Visiongain Ltd